COVID vaccines offer the pharma industry a once-in-a-generation opportunity to reset its reputation. But it’s after decades of big profits and scandals

Research output: Contribution to journalOnline ResourceProfessional

Abstract

Just weeks before the first COVID-19 cases emerged, Gallup published its latest poll on America’s views about business. At the bottom of the list of 25 sectors was the pharmaceutical industry. Below advertising. Below oil and gas. Below the banks.

The pandemic and the new vaccines have of course turned that reputation around, but let’s not forget why the pharmaceutical industry’s credibility sank so low.
Original languageEnglish
JournalThe Conversation
Publication statusPublished - 4 Aug 2021

Fingerprint

Dive into the research topics of 'COVID vaccines offer the pharma industry a once-in-a-generation opportunity to reset its reputation. But it’s after decades of big profits and scandals'. Together they form a unique fingerprint.

Cite this